Clinical Trials Logo

Clinical Trial Summary

The Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction(SOD) study (EPISOD) is a randomized sham-controlled study of biliary and pancreatic sphincterotomy as treatment for patients with pain after cholecystectomy fitting the criteria for sphincter of Oddi dysfunction type III.


Clinical Trial Description

Clinical Trial Phase: Phase III

Study Sites Seven clinical centers in US

Study Period Planned enrollment period - 3 years

Planned duration of the study - 5 years

Study Population SOD III Patients

Primary Study Objective: To ascertain whether subjects with SOD III respond to sphincterotomy,

Secondary Study Objectives

To evaluate:

- the association between the results of Sphincter of Oddi Manometry (SOM) (abnormal/normal) and the primary outcome (success/failure);

- the success rate (as defined in the primary) of subjects who receive biliary sphincterotomy alone versus subjects who receive both biliary and pancreatic sphincterotomy in the subgroup of patients with manometrically proven hypertension of the pancreatic sphincter;

- the effects of pre-specified prognostic factors on the primary outcome;

- anxiety and depression scores over time and their relation to study outcomes;

- the economic impact of SOD III, and of endoscopic sphincterotomy in patients with SOD III; and, to,

- conduct a careful follow-up study (EPISOD2) of standard of care treatment (separate protocol).

Study Design The EPISOD Trial is a parallel, randomized, double-blinded, sham-controlled, multicenter Phase III clinical trial of endoscopic sphincterotomy as treatment for adults 18 to 65 years of age diagnosed with SOD III.

Sample Size A minimum of 214 subjects will be randomized using a 2:1 allocation in favor of sphincterotomy and will be followed for 12 months post-randomization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00688662
Study type Interventional
Source Medical University of South Carolina
Contact
Status Completed
Phase N/A
Start date July 2008
Completion date December 2016

See also
  Status Clinical Trial Phase
Terminated NCT01410071 - Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction N/A
Completed NCT02916199 - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method N/A
Recruiting NCT02833103 - Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction Phase 4
Completed NCT00471315 - Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction) Phase 3
Completed NCT01134848 - A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers Phase 4
Recruiting NCT03977779 - Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis N/A
Recruiting NCT03999333 - Virtual Reality in SOD N/A
Not yet recruiting NCT06315179 - Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)